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Abstract
Radiation therapy (RT) is a widely accepted treatment strategy for many central nervous system (CNS) pathologies.
However, despite recognized therapeutic success, significant negative consequences are associated with cranial irradiation
(CR), which manifests months to years post-RT. The pathophysiology and molecular alterations that culminate in the long-
term detrimental effects of CR are poorly understood, though it is thought that endothelial injury plays a pivotal role in
triggering cranial injury. We therefore explored the contribution of bone marrow derived cells (BMDCs) in their capacity to
repair and contribute to neo-vascularization following CR. Using high-resolution in vivo optical imaging we have studied, at
single-cell resolution, the spatio-temporal response of BMDCs in normal brain following CR. We demonstrate that BMDCs
are recruited specifically to the site of CR, in a radiation dose and temporal-spatial manner. We establish that BMDCs do not
form endothelial cells but rather they differentiate predominantly into inflammatory cells and microglia. Most notably we
provide evidence that more than 50% of the microglia in the irradiated region of the brain are not resident microglia but
recruited from the bone marrow following CR. These results have invaluable therapeutic implications as BMDCs may be a
primary therapeutic target to block acute and long-term inflammatory response following CR. Identifying the critical steps
involved in the sustained recruitment and differentiation of BMDCs into microglia at the site of CR can provide new insights
into the mechanisms of injury following CR offering potential therapeutic strategies to counteract the long-term adverse
effects of CR.
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Introduction
Radiation Therapy (RT) plays a pivotal role in the treatment of
many CNS pathologies including CNS neoplasms, both primary
infiltrative and metastatic brain tumors, and non-neoplastic
disease processes, such as arterio-venous malformation [1,2].
Unfortunately CR has significant adverse effects on the normal
CNS, causing acute changes predominantly associated with CNS
edema and debilitating cognitive decline, which manifest months
to years after treatment. Paradoxically, patients who successfully
survive their initial disease are left to face a progressive and severe
decline in learning, memory and executive brain function [3].
Elucidating the precise molecular mechanisms that culminate in
the adverse radiation effects following CR is crucial in preventing
decline in function for future patients who require CR.
Postulated mechanisms of radiation-induced cranial injury
include cyclic chronic inflammation, loss of oligodendrocytes and
microvascular injury [4]. Recent research interest has focused on
the reparative and therapeutic role that BMDCs can play in a
number of CNS pathologies, including brain tumors, stroke,
multiple-sclerosis and spinal cord injury
[5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20]. The potential for
BMDCs to play a similar reparative and therapeutic role in
normal brain following CR has, so far, not been investigated,
although Kioi et. al., did demonstrate a significant contribution of
BMDCs to brain tumor neo-vascularization [18]. Traditional
histological methods are invaluable for tissue analysis however,
they provide only ‘snap-shot’ cross-sectional information about the
vasculature. Dynamic integration between different cell types and
in-vivo tracking of cell migration is not possible with traditional
cross-sectional analysis. Therefore, to complement histological
analysis, we have taken advantage of 2Photon Laser Microscope
(2PLM) high-resolution in vivo imaging of chimeric mice with
fluorescent bone marrow chimeric mice. This experimental
strategy has allowed us to visualize BMDCs at a single-cell level
in normal brain and brain associated vasculature, longitudinally in
real-time, to determine the spatio-temporal contribution of
BMDC to neo-vascularization and in response to RT. Using this
experimental strategy we demonstrate for the first time that there
is a specific spatio-temporal and radiation dose-dependent
recruitment of BMDCs that occurs following CR to normal brain.
BMDCs persist, at the site of CR, long after the delivery of
radiation, they migrate outside the vessel lumen and some encircle
the vessel in part as smooth muscle cells, but do not form EC. Most
notably our results establish that inflammatory progenitors are
mobilized from the bone marrow, rather than being brain-resident
inflammatory cells. This particular result provides invaluable
therapeutic implications as BMDCs may be a primary therapeutic
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38366target to block acute and long-term inflammatory response
following CR.
Results
BMDCs are recruited specifically to the site of CR
Using 2PLM imaging we observed a distinctive pattern of
recruitment of BMDCs to the site of CR, as evidenced by the
presence of Green Fluorescent Protein (GFP)
+BMDCs as early as
1 hour post-RT, in a trajectory that parallels the radiation path in
a cranial-caudal direction as seen with both immunofluorescence
analysis and 2PLM imaging at the site of the Intra-Cranial
Window (ICW) (Figure 1A,B,C). In order to confirm that the
green fluorescent signal is not due to auto—fluorescence we used
red fluorescent protein (RFP
+BMDC) chimeric mice and see the
same pattern of recruitment of BMDC to site of CR with no GFP
+
signal evident (Figure 1D). The advantages of using a 2PLM in-vivo
approach over traditional histological studies is significant, as
illustrated by quantification of BMDCs recruited to the site of CR
per volume of tissue (Figure 1E). There is a ten–fold increase in the
number of detectable BMDCs in 2PLM, through the examination
of multiple z-stacked images, when compared with traditional
histology. Infiltration of GFP
+BMDCs is very specific to the site of
CR with minimal GFP
+BMDCs present outside of the direct
radiation beam. Furthermore, immunofluorescence examination
of the contra-lateral non-irradiated hemispheres (Figure 1B), plus
2PLM images of control brains of non-irradiated mice (Figure 1C)
showed minimal GFP
+BMDC recruitment when compared to
irradiated normal brain. To confirm that our observations were
not dependant on mouse strain we demonstrate a similar pattern
of recruitment in many strains of mice (ICR, Balb/C5 and
NODSCID). We also saw the same pattern of recruitment in both
our immediate (7 day post bone marrow transplant) and chronic
(60+day post bone marrow transplant) chimeric models demon-
strating no difference between BMDC recruitment between
immediate circulating BMDC and complete reconstitution of
BMDC. Furthermore, to verify that total body irradiation (TBI)
does not bias our results of BM recruited to site of CR we used
lead cranial shielding during TBI for BM reconstitution.
Recruitment of BMDCs is radiation dose-dependent
Recruitment of BMDCs to the site of CR is radiation dose
dependent. We delivered single doses of radiation, ranging from 2
to 15 Gy, plus two daily fractionated radiation regimens of 362Gy
and 365Gy to the normal brain through the ICW. Using 2PLM
imaging we demonstrated a visible increase in the extent of
BMDC recruitment to the site of CR with radiation dose
(Figure 2A,B), with the highest response seen at 15Gy at all time
points post-RT. Quantifying the extent of BMDC recruitment
demonstrates that with each higher radiation dose there is a
statistically significant increase in BMDC recruitment (p,0.0001),
with minimal BMDCs present on the contra-lateral left non-
irradiated hemispheres (Figure 2C).
Recruitment of BMDCs is time-dependent
We monitored the recruitment pattern of BMDCs to the site of
CR using 2PLM over a longitudinal period from 1 hour to 1
month post-RT. BMDC recruitment was seen as early as 1 hour
post-RT, significantly increased by day 7 and then was maintained
at a sustained level up to 1 month post-RT (Figure 3A). The
recruited BMDCs persisted in the radiation field with no
significant migration beyond the site of radiation. There was a
distinctive and sustained presence of BMDCs at the site of CR well
beyond the initial delivery of RT. This was not explained by
proliferation of the initial population of BMDCs recruited to the
site of CR, as established by lack of positive Ki67/BrDU staining
of BMDCs (data not shown). We compared recruitment of BMDCs
in response to CR in normal brain with a blunt needle trauma to
the normal brain. Blunt needle trauma in the frontal cortex
resulted in early recruitment of BMDCs to the site of needle injury,
however, the presence of BMDCs diminished rapidly after 7 days
and was completely lost by 21 days (Figure 3B). Quantification of
the BMDCs recruitment demonstrates the dramatic patterns seen
in both models (Figure 3C)
Investigating Mechanisms of BMDC recruitment: Stromal
Cell Derived factor 1
We examined whether stromal-cell derived factor (SDF1)/
CXCR4 signaling pathway was involved in the recruitment of
BMDCs to the site of CR in normal brain. We treated animals
with AMD3100 either two weeks prior to RT or concurrently with
RT and examined alterations in the pattern of subsequent BMDC
recruitment. We found no change in the extent of BMDC
migration to the site of CR in normal brain following treatment
with AMD3100, regardless of radiation dose or time course
following RT (Figure 3D,E).
Radiation induced microvascular alterations
Microvascular injury, specifically endothelial cell (EC) apopto-
sis, is considered to play a pivotal role in radiation-induced cranial
injury. We assessed the extent of EC apoptosis in a longitudinal
and radiation dose dependent manner and in relation to the extent
of BMDC recruitment, through double immunohistochemical
staining for EC (CD31) and apoptosis (TUNEL) according to
previous published protocols by Fuks et al [21,22]. A statistically
significant (p,0.0001) increase in EC apoptosis (CD31
+ TUNEL
+)
was observed with each increasing radiation dose, from 2Gy to
15Gy (Figure 4A,B). The highest degree of EC apoptosis occurred
at 1 hour post-15Gy RT and diminished thereafter in a radiation
dose and time dependent manner, decreasing significantly by 1
day post-RT, (p=0.0001). At radiation doses less than 6Gy
minimal EC apoptosis was observed. We also quantified overall
apoptotic cells in the normal brain parenchyma (TUNEL
+). The
peak of apoptosis in the normal brain parenchyma occurred
significantly later than EC specific apoptosis, with the highest level
seen 1 day post-RT (p=0.0224). The highest degree of
parenchymal TUNEL
+ cells was seen in response to 15Gy, which
was significantly higher than that seen with the other radiation
doses (p=0.0075) (Figure 4C). We analyzed alterations to vascular
structure in response to CR by measuring microvascular density,
vessel diameter and vessel leakiness. There was a statistically
significant increase in vessel diameter by 7 days post-RT together
with an increase in microvascular density (p,0.0001)
(Figure 4D,E). Increased vessel leakiness was detected at 7 days
following CR using Evans Blue perfusion fixation (Figure S1A).
We investigated whether there was an associated change in
cerebral blood flow (CBF) with ultrastructural changes observed in
the vasculature at the site of CR. We used MRI flow-alternating-
inversion-recovery techniques to measure CBF, comparing irra-
diated (R) hemisphere to non-irradiated (L) hemisphere. We found
that at site of CR associated with the area of increased MVD and
dilated vessels there was no significant change in CBF (Figure S2).
Contribution of BMDCs to vascular elements following
cranial irradiation
We took advantage of our 2PLM in-vivo intra-vital imaging
strategy to examine in-vivo differentiation of BMDCs intracranially
BMDC Recruitment following Cranial Irradiation
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tiate to form EC. We used intravenous injection of CD31
+ tagged
Allophycocyanin (APC) antibody to allow specific in-vivo identifi-
cation of vessel ECs. Additionally, the use of time-lapse footage
(Video S1) and z-stack imaging (Video S2) provided detailed
information on three-dimensional correlation of BMDCs with the
vasculature and in depth analysis of their relationship to the vessel
wall and vessel ECs (Video S2 & Figure S3). BMDCs did not
Figure 1. Bone Marrow Derived Cells Migrate Specifically to the Site of Cranial irradiation. (A) H&E staining of a normal brain 7 days
following 3*2Gy radiation illustrates the location from where immunofluorescence images in (B) were obtained, 26magnification. Black arrowhead
shows the positioning of the intracranial window (ICW) and so the radiation path. (B) The right irradiated hemisphere demonstrates a trajectory of
bone marrow derived cell (BMDC) recruitment which follows a cranial-caudal direction, with maximal recruitment at the cortex gradually decreasing
beneath the cortical surface, compared to the contralateral-left, non-irradiated hemisphere which shows no BMDC recruitment (Green: BMDC, blue:
nuclei), 106magnification. (C) 2 photon laser microscopy in-vivo images 7 days post 3*2Gy radiation, illustrate distinct BMDC recruitment to the site
of cranial radiation, whilst non-irradiated control brains demonstrate minimal incorporation of BMDCs (Green: BMDC, red: blank, blue: CD31-APC), 56
magnification. (D) To confirm that recruitment of BMDCs visualized on 2 photon laser microscopy is not as a consequence of green auto-fluorescent
signals, red fluorescent chimeric mice were used to demonstrate a similar pattern of BMDC recruitment following 3*2Gy radiation but demonstrate a
negative green channel (Green: blank, red: BMDC, blue: CD31-APC), 106 magnification. (E) Quantification of BMDCs visualized per field of tissue
volume for 2PLM, blue bars, and traditional histology, black line. Note, the 10-fold difference in the scale bars highlighting the statistically significant
difference in sensitivity of the 2 methods. This figure highlights the distinct advantage of 2 photon laser microscopy in-vivo imaging over traditional
5 mm cross-sectional histological analysis, clearly allowing visualization of higher levels of BMDCs in the same region of the brain, comparing (B)t o
(C) which when quantified in context of tissue volume (E) shows 2PLM is 10-fold more sensitive than traditional histology.
doi:10.1371/journal.pone.0038366.g001
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radiation dose. On 2PLM images we saw BMDC migrate to the
site of CR, migrate outside of the vessel lumen, where a
subpopulation went onto encircle the vessel, but did not form
CD31
+APC cells. Migration of BMDCs out of the vessel lumen
was independent of vessel size, caliber or location along the course
of the vessel. There was no difference between branching points in
comparison to regions along the vessels between branching points.
This is in contrast to what is reported for cancer cell metastases by
Winkler et al where a majority of metastatic cancer cells migrate
out of the tumor vasculature at sites of branching [23].
Immunofluorescence and immunohistochemical analysis both at
site of CR and outside the radiation field did not show any co-
localization of CD31
+ cells with BMDCs (Figure 5A,B). Immuno-
fluorescence staining for smooth muscle actin (SMA) confirmed a
small, although not statistically significant, increase in the extent of
SMA
+ BMDC that surrounded the vasculature in the area of CR,
compared to the contralateral control non-irradiated brain.
However, the majority of peri-vascular BMDCs are not SMA
+
(Figure 5C) rather they are inflammatory and microglial-like cells
as described below.
BMDCs differentiate to form specific cell types, beyond
vascular elements
We used immunohistochemical analysis to examine the cell
types into which recruited BMDC differentiate using a panel of
antibodies (CD31, SMA, MAC3, CD11b. CD11c, F4/80, IBA1,
GFAP) for inflammatory, immune, vascular and brain cells. Of all
cell types explored two cell population predominated: inflamma-
tory cells and microglia. Using a panel of pro- and anti-
inflammatory markers; Mac3, CD11b, CD11c, F4/80, we
demonstrated that approximately 40% of the recruited BMDCs
in the brain are inflammatory cells (Figure 5D,E). At the site of CR
most, if not all, of the inflammatory markers co-localize with
BMDC, suggesting recruited progenitors from the bone marrow
and not brain resident inflammatory cell populations are
responsible for initiation of the inflammatory response seen post-
RT.
The second significant cell type that BMDCs differentiated into
was microglia. BMDCs recruited to the site of CR formed
microglia or perhaps more accurately microglia-like cells in a
radiation dose dependent manner. These bone marrow derived
microglia were seen in addition to resident microglia in the brain
parenchyma and in peri-vascular regions (Figure 5F,G). Above
doses of 6Gy, approximately 50% of the detectable microglia were
bone marrow-derived, with the other half being resident microglia
that showed no co-localization with BMDCs (Figure S1B).
Minimal levels of bone marrow derived microglia were seen
outside the site of CR or in the non-irradiated contra-lateral
hemispheres of the mice.
Discussion
Cranial irradiation (CR) plays an invaluable role in the
treatment of various CNS pathologies [3,24], including all primary
and metastatic brain tumors and other non-oncological processes
such as vascular malformations of the brain. Despite the
recognized therapeutic efficacy of CR there are significant
negative consequences on normal brain. Little is understood
about the molecular mechanisms responsible for the adverse
effects following CR. In this study we have shown for the first time
using in-vivo high-resolution imaging, that BMDCs are recruited to
the site of CR in a highly distinct temporal-spatial and radiation
dose dependent manner (Figure 1,2). Taking advantage of the high
resolution of optical imaging we have been able to confirm a
distinctive pattern of BMDC response that has previously not been
detected with use of routine histological analysis. BMDCs were
seen specifically at the site of CR and minimally outside of the
radiation field or in non-irradiated brains. There was a statistically
significant increase in the extent of BMDCs recruited to the site of
CR with increasing radiation dose. These findings are a critical
first step in understanding the involvement of BMDCs in response
to CR.
Disruption of the blood-brain barrier (BBB) is a consistent and
recognized event following radiation injury to the brain, resulting
in increased vascular permeability and leakiness of vessels [25,26].
We observed dilated vessels with increased leakiness at the site of
CR as demonstrated by Evans blue extravasation from the
intracranial vasculature at site of CR (Figure S1A). Thus presence
of BMDCs at the site of CR might be explained by direct influx of
Figure 2. Bone Marrow Derived Cell Recruitment is Radiation
Dose-Dependent. (A,B) Increasing levels of BMDC recruitment can be
observed with increasing radiation doses on 2 photon laser microscopy
in-vivo imaging 7 days post radiation (Green: BMDC, blue: CD31-APC),
106 magnification. (A) Single dose increase from 2Gy to 15Gy, (B)
fractionated doses increase from 3*2Gy to 3*5Gy, all demonstrate an
increase in BMDC recruitment. (C) Bar graph representing quantification
of the extent of BMDCs recruited to site of cranial radiation 7 days post,
demonstrating a statistically significant increase in BMDC recruitment
between 2Gy to 6Gy and 2Gy to 15Gy, both p,0.0001***. Fractionated
radiation demonstrates lower rate of BMDC recruitment when
compared to its single fraction equivalent, perhaps explained by
radiobiology principle of repair that occurs with fractionated radiation.
The increase in BMDC recruitment is noted at all time points post
radiation (1 hour, 1 day, 21 day).
doi:10.1371/journal.pone.0038366.g002
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of migration of BMDCs recruited to the site of cranial radiation is distinct from that seen in response to intracranial trauma. Using intra-vital EC
staining antibody (CD31) it is clear that BMDCs do not contribute to vascular endothelial cells. (Green: BMDC, blue: CD31-APC), 56 magnification,
unless stated. (A) BMDCs recruited to the site of 3*2Gy radiation in normal brain persist up to 1 month post radiation therapy, with a steady increase
in extent of BMDCs present from day 1 up to day 21 as seen in the 2 photon laser microscopy images. BMDCs do not migrate or invade into the
surrounding brain parenchyma with time, but stay within the radiation trajectory. (B) In control mice that received no radiation but received sham
needle injection, there is evidence of BMDC recruitment to the site of injury within 24 hours of the sham injection but it rapidly diminishes before day
7 and is completely lost by day 21. (C) Quantification of the average BMDCs in high powered fields demonstrates the difference in patterns between
RT and blunt traume. (D,E) AMD3100, an inhibitor of the Stromal-cell Derived Factor1/CXCR4 pathway, did not inhibit BMDC recruitment post
radiation as shown in the 2 photon laser microscopy images (Green: BMDC, blue: CD31-APC), 56 magnification. (D) AMD3100 was administered
concurrently with radiation and BMDC recruitment was unaffected from day 3 to day 10 post radiation. (E) Pretreatment with AMD3100 prior to
radiation also did not show any significant difference in BMDC recruitment.
doi:10.1371/journal.pone.0038366.g003
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integrity. Previous data has reported that lymphocytes are
recruited to the site of RT injury and can attach to vessel EC
and infiltrate into normal brain parenchyma [27,28]. We
examined this possibility by staining for possible peripheral blood
cells such as erythrocytes, granulocytes, megakaryocytes, Natural
Killer cells, T and B cells using immunohistochemistry and
immunofluorescence analysis in addition to 2PLM imaging.
BMDCs recruited to the site of CR did not stain positively for
the lymphocytes markers; CD3 and B220, and very few BMDCs
showed characteristics of red blood cells at the site of CR implying
that BMDCs present at the site of CR do not simply represent an
influx of peripheral blood through disrupted BBB of intracranial
vessels. Another explanation is that BMDCs contribute to long-
Figure 4. Microvascular Alterations Post Radiation. Immunohistochemical co-staining of CD31 and TUNEL confirms endothelial cell apoptosis
occurs as early as 1 hour post radiation at site of cranial radiation. (A) Increasing radiation doses from 2Gy to 15Gy increases endothelial cell
apoptosis as seen in immunohistochemistry sections (Brown: CD31, Pink: TUNEL),4 0 6 magnification. (B) Graphical representation of endothelial
apoptosis, CD31
+ TUNEL
+, illustrates that 15Gy significantly induces the most endothelial apoptosis when compared to 2Gy and 6Gy at 1 hour post
radiation, (p=0.0001***) and that endothelial cell apoptosis levels at 15Gy 1 hour post radiation are significantly increased compared to 1 day post
radiation, (p=0.0004**). (C) Quantification of apoptosis of total parenchymal cells shows that 15Gy significantly induces most apoptosis
(p=0.0075**) at 1 day post radiation, however significantly more apoptosis is induced 1 day post radiation than at 1 hour post radiation (p=0.0224*).
Compared with what is seen with endothelial cell apoptosis it is clear that maximal endothelial cell apoptosis occurs earlier than overall parenchymal
cell apoptosis. (D) Further analysis of vessels structure at the site of radiation, 7 days post 3*2Gy, demonstrates significant increases in both the
density, p,0.0001***, and diameter of vessels, p,0.0001***, when compared to non-irradiated controls. (E) CD31 immunohistochemistry sections
confirm the change in vessel density and diameter 7 days following 3*2Gy radiation when compared to non-irradiated control tissue, 106
magnification.
doi:10.1371/journal.pone.0038366.g004
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tested using GFAP (Figure 5H) and reticulin stains and no co-
localization of BMDC was observed.
There was sustained BMDC recruitment long after the initial
delivery of RT to the normal brain, which was not explained by
proliferation of the initial population of BMDC recruited to site of
CR. The fact that BMDCs persist specifically at the site of CR
implies a continued level of injury, possibly reflecting the process
of apoptosis of ECs or other cells, such as oligodendrocytes, which
in turn would release cytokines and chemokines [24] that trigger
BMDC recruitment. SDF1/CXCR4 is the signaling pathway most
implicated in regulating recruitment and migration of BMDCs in
tumor models [18,20,29]. AMD3100 is a known inhibitor of the
SDF1 pathway and has been shown to cross the BBB to diminish
or obliterate BMDC recruitment in intracranial tumor models. We
explored the possibility that SDF1/CXCR4 mediated the
recruitment of BMDCs in response to CR in normal brain.
However, we found that AMD3100 did not block recruitment of
BMDC to site of CR, regardless of radiation dose or time course
following RT (Figure 3C,D). There is evidence to suggest that
SDF1/CXCR4 signaling of BMDCs is highly dependent on the
microenvironment [18,20,29] and based on our results SDF1/
CXCR4 does not appear to play a significant role in recruitment
of BMDC in the context of CR in normal brain. These initial
studies are an attempt to investigate the mechanism responsible for
BMDC recruitment, but further studies are required to fully
elucidate the precise signaling pathways involved since the most
recognized pathway, SDF1, does not appear to be involved
following RT.
Considerable current research is focused on the contribution of
BMDC to de novo vessel formation or the process of vasculogenesis
in response to insults such as ischemia or tumor growth
[20,30,31,32,33,34,35]. Most relevant, is the recent eloquent
study by Kioi et.al. which demonstrated that vasculogenesis is
relevant to tumor reoccurrence and progression following RT
[18]. Given the central role that microvascular injury plays in
triggering radiation induced injury [21,28,36,37,38,39,40,41], we
examined the potential role that BMDCs play in repairing injured
microvasculature in normal brain. In particular, we focused on
whether BMDCs differentiated into the full complement of cells
necessary to compose a functional vessel to aid the process of
vasculogenesis and directly replace apoptotic EC or, more
indirectly, whether BMDCs form peri-vascular support cells to
help in the repair of injured microvasculature.
The extent of EC apoptosis following CR remains controversial,
as results vary between studies [25,39,42,43]. Therefore, we first
established extent and timing of EC apoptosis in relation to
BMDC recruitment in our experimental model. Endothelial cell
apoptosis precedes brain parenchymal cell apoptosis by approx-
imately 24 hrs (Figure 4B). Though EC apoptosis precedes BMDC
recruitment, BMDC recruitment is sustained well after EC
apoptosis (beyond 7 days), supporting the possibility that released
chemokines and cytokines continue to maintain memory of RT
injury. In addition to EC apoptosis, alterations in vascular
architecture and microvascular density are evident as a conse-
quence of CR. There is a statistically significant increase in vessel
diameter by 7 days post-RT that persisted beyond 1 month
without repair (Figure 4D,E). It appears that the timing of BMDC
recruitment follows a peak in EC apoptosis in the CNS. These
results are in keeping with previous published data that suggests a
pivotal role for EC apoptosis triggering a cascade of molecular
events that culminates in cellular injury in the CNS. Following
CR, recruited BMDCs migrate outside of the vessel lumen, where
a subpopulation remain intimately involved with the vasculature
and encircle the vessel lumen. At no stage post-RT did we observe
recruited BMDCs to form EC regardless of radiation dose. A
percentage of BMDCs surrounding the blood vessels exhibit
smooth muscle cell characteristic, however the majority of peri-
vascular BMDCs are not SMA
+ (Figure 5C). This can be
explained by differential stages of smooth muscle cell maturity
and differentiation or that BMDCs which encircle the vessel lumen
provide a supportive role that is distinct from that provided by
normal SMC. Our observation that BMDCs do not replace
Figure 5. Characterization of Bone Marrow Derived Cells. (A–H)
Immunofluorescence analysis of brain sections for characterization of
cell types that BMDCs potentially differentiate to at the site of cranial
radiation 7 days post 6Gy radiation, in the staining a red fluorescent
chimeric mouse was used. (Green: stain, Red: BMDC, Blue: nuclei), 406
magnification (A,B) No differentiation of BMDCs to vessel endothelial
cells is evident, confirming what was seen on the 2 photon laser
microscopy in-vivo imaging. (A) BMDCs do not co-localize with the
endothelial cell marker CD31, using confocal immunofluoroscence, or
(B) immunohistochemical overlay of CD31 (Brown: CD31), 106
magnification. (C) Few BMDCs co-localize with the pericytic differen-
tiation marker smooth muscle actin, shown by white arrowhead. (D,E)
Approximately 40% of recruited BMDCs stain positively for inflamma-
tory markers: (D) MAC3, co-localization shown by white arrowhead, (E)
CD11b, co-localization shown by white arrowhead. (F) 50% of recruited
BMDCs found in the parenchyma co-localize with the microglial
differentiation marker IBA1 shown here by white arrowhead. (G)
IBA1
+ BMDCs are also found in the perivascular space around vessel
wall, shown by white arrowhead. (H) There was no astrocytic
differentiation or glial scaring, as determined by the lack of GFAP co-
localization.
doi:10.1371/journal.pone.0038366.g005
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from the recent study by Kioi et.al. and other groups that showed
distinct differentiation of BMDCs to form ECs following RT in
glioma models [18,19,20,44,45,46,47]. Taken together, prior
studies have predominantly focused on the contribution of BMDC
in tumor models and have suggested that possibly an oncogenic
signal may be necessary to promote and drive BMDCs differen-
tiation to an EC fate and contribute to vasculogenesis. However, in
the context of CR in normal brain, and perhaps in the absence of
an oncogenic signal, we do not see any differentiation of BMDCs
to form EC.
Acute and chronic cyclic inflammations are postulated mech-
anisms involved in radiation induced cranial injury, however, the
origins of the inflammatory response has never been established
[48,49,50]. Our results confirm, for the first time, that the
inflammatory response seen in the brain post-RT is largely
mediated through mobilization of bone marrow derived inflam-
matory progenitors and not by inflammatory cells resident in the
brain, demonstrated by the lack of inflammatory cells that are not
GFP
+BMDC at site of CR (Figure 4D,E). The peri-vascular
localization of some of the inflammatory BMDCs suggests they
may play a role in the initial steps of repair of apoptotic and
damaged vessel endothelium.
A critical finding in this study is the differentiation of BMDCs to
form microglia. Microglia are recognized as a unique macrophage
population within the CNS, and are considered both as cells of
neuroepithelial origin and as mononuclear phagocytes involved in
inflammatory and immune responses [51]. They play a crucial role
in neuronal development during embroygenesis [52,53,54,55] and
during adult life their principle role is thought to be protective,
either through an anti-inflammatory role, removing debris and
dead tissue in an attempt to restore normal tissue function [56] or
via release of neurotrophic factors that have essential roles in
neuroprotection and repair [57]. There is significant controversy
surrounding the origins of microglia, highlighted by the recent
community corner review in Nature Medicine 2010 [58]. Though
microglia in the developing CNS are thought to be derived from
myeloid-monocytic lineage cells, in the adult brain the BBB
heavily regulates microglia, and so the origins of adult microglia in
the CNS and how they are replenished remains disputed [56].
Most current literature suggest that peripheral myeloid cells from
fetal and adult hematopoiesis contribute minimally if at all to adult
microglia in the CNS [58]. Previous studies in irradiation chimera
models show only a 5% engraftment of microglia from reconsti-
tuted bone marrow [59] but no studies have focused specifically on
response of microglia and its origins in CR. Mildner et. al,
demonstrated recruitment of monocytes to demylinating brain
from bone marrow and observed that they differentiated into
microglia [60]. Here we demonstrated that in irradiated brain
BMDCs are recruited and in a dose dependent manner constitute
up to 50% of the microglia at the site of CR but there is minimal
contribution of BMDCs to microglia outside of the radiation field.
The plasticity and tremendous potential for differentiation and
transformation of BMDC into cells relevant to the microenviron-
ment and disease site has been shown previously by a number of
authors [60,61]. Most relevant to this study, Piller et. al.
demonstrate differentiation of BMDC into neuronal phenotypes,
specifically Purkinje neurons, 1–6 months following bone marrow
transplantation [61]. More recently Nern et. al. demonstrate a
transient phenomenon which argues that in fact BMDCs fuse with
resident purkinje cells rather than transforming into them [62].
Our data is in support of the ability for BMDC to differentiate into
microglia or microglia-like cells in response to the microenviron-
mental requirement of irradiated normal brain.
Our key novel findings include a specific temporal-spatial and
radiation dose dependent recruitment of BMDCs that occurs
following CR to normal brain. BMDCs persist long after the initial
insult of radiation injury and remain at the site of CR with
minimal migration outside the radiation field. BMDCs migrate
outside the vessel lumen to encircle the vessel in part as smooth
muscle cells, but predominantly as inflammatory cells and
microglia, to possibly provide a vascular support or reparative
role. BMDCs do not form EC or regulate de novo vessel formation
or vasculogenesis at any radiation dose or time course following
CR.
Our results identify that inflammatory progenitors mobilized
from the bone marrow, versus those brain resident inflammatory
cells, are the primary source of the acute and chronic inflamma-
tory response that is considered to trigger the onset and
progression of neural injury seen post-RT. This particular result
provides invaluable therapeutic implication as BMDCs may be the
primary therapeutic target to block acute and long-term inflam-
matory response following CR. Most notably we provide evidence
that more than 50% of the microglia are not resident microglia but
are recruited from the bone marrow following CR. In disease
processes such as Alzheimer’s bone marrow derived microglia
have a more efficient therapeutic potential compared with resident
microglia in eliminating amyloid plaques [63,64]. Therefore, it is
highly relevant to explore the therapeutic potential of microglia
derived from BMDCs in response to CR in order to diminish or
counteract the adverse effects seen following CR.
Methods
For all experiments, a total of 15 chimeric NODSCID mice
were generated for each condition. This allowed five mice per time
point to be imaged using the 2PLM and two mice to be sacrificed
for histological analysis and additional mice accounted for animal
loss. All experiments, CR, needle trauma and control were
repeated in triplicate. We used both immediate (7 day post BMT)
and chronic (60+day post BMT) chimeric models. We examined
the brains using 2PLM and histological analysis at 1 hr, 24 hr,
3day, 7day, 10day, 14day and 21day post radiation and needle
trauma (Figure S4).
Bone Marrow Reconstitution
NOD/SCID, ICR background and Balb/C5 chimeric mouse
models were created to have GFP+ or dsRED (RFP)+ bone
marrow through bone marrow reconstitution [29,33]. Briefly,
donor transgenic mice constitutively expressing green or red
fluorescent protein (GFP/RFP) were sacrificed according to
institutional guidelines and bone marrow was harvested from
both tibias and femurs into 1 ml of sterile saline (VWR). Eight-
week old recipient mice were lethally irradiated with 3Gy total
body irradiation using a Gamma Cell 40 irradiator (Nordion
International). To ensure results were not biased by exposing the
brain to irradiation cranial shielding was used. 6610
6 donor-
derived bone marrow cells were injected intravenously via the
dorsal tail vein. Efficient reconstitution was confirmed by post-
sacrifice examination of bone marrow and circulating blood for
GFP
+ or RFP
+cells for every study time point up to six months to
confirm complete BMDC engraftment, with approximately 70%
engraftment seen. For every experimental mouse BM and blood
was collected to ensure equal percentage of BM engraftment at
time of necropsy (Figure S5).
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Mice were anaesthetized using 0.5 mg/g of Avertin (Sigma
Aldrich) and 5 mg/kg of pre-surgical analgesic Caprofen.
TearGel (Novartis) was applied to prevent corneal dehydration.
A mid-line scalp incision was made from the ears to the eyes to
expose the skull and the underlying periosteium was frozen with
2% Lidocaine:Epinephrine (Bimeda MTC) before dissecting away.
A high-speed drill with a 2.7 mm trephine (Fine Science Tools)
was used to generate a circular bone flap in the right frontal skull.
The cortical surface was kept hydrated using saline and a 5 mm
glass coverslip (Warner Instruments) was placed over the window.
The skull surface was dried and self-curing dental acrylic
(Bosworth) was used to seal the coverslip onto the skull surface.
Drug therapy
AMD3100 resuspended in saline was administered to mice
1.25 mg/kg twice daily subcutaneously for a continuous two-week
period either beginning with RT or given 2 weeks prior to RT.
Stereotactic Radiation Therapy
Mice were anaesthetized using isofluorane at 4% for induction
followed by 1.5–2% throughout the procedure with 0.5–1 liter O2
a min. Mice were placed on a custom-made frame designed to
immobilize the head, and the frame placed inside a micro-
irradiator (Precision Xrad 225Cx) set up in-house for in-vivo
targeted RT research. A 360u Computer Tomography scan of the
mouse inside the Xrad was taken with the Xray tube running at
40 kVp and 0.05 mA through a 2 mm Aluminium filter, and was
used to adjust the platform to centre the RT beam to the right
hemisphere, specifically the ICW. RT was administered through a
8m m 611 mm collimator, with the Xray tube running at 225 kVp
and 13 mA, through a 0.93 mm Copper (Cu) filter, from the top
(dorsal) and from the bottom (ventral) of the gantry (Figure S6).
Optical Imaging
At specified time points (1 hr, 24 hr, 3 dy, 7 dy, 10 dy, 14 dy,
21 dy) mice were anaesthetized using 0.5 mg/g of Avertin (Sigma
Aldrich). Ten minutes prior to imaging Allophycocyanin (APC)
tagged CD31 antibody (BDPharmingen), 0.2 mg/g, was intrave-
nously injected. The mouse was inverted onto custom-built
restrainer, designed to stabilize head perpendicular to the laser,
and mounted onto 2PLM-automated stage. GFP, RFP and APC
were excited with 488 nm, 543 nm, 633 nm wavelengths respec-
tively and emissions collected using the BP500-550IR, BP565-
615IR, BP650-710IR filter sets respectively using a line step of 1
and averaging of 4. Time elapsed videos were made using a line
step of 8 and average of 1, to highlight movement of the BMDCs
in the field, for 150 msec continual loops (Video S1). Z-Stack
images were acquired using 5 mm intervals over 50–100 mm depth
of field with reduced averaging of 2 to reduce imaging time (Video
S2).
Measuring Cerebral Blood Flow using Magnetic
Resonance Imaging (MRI)
MR imaging was performed with a 7 Tesla Biospec 70/30
(Bruker Corporation, Ettlingen, DE), using the B-GA12 gradient
coil insert and 7.2 cm inner diameter linearly polarized volume
resonator coil for Radio Frequency (RF) transmission. Mice were
oriented in supine position on a slider bed and maintained at 1.8%
isoflurane. A dedicated murine head coil was used for RF
reception. Neuroperfusion (P) was quantified in a single transverse
imaging slice, predefined to highlight the hippocampal region,
using a flow-alternating-inversion-recovery (FAIR) technique,
which quantifies the difference in T1 relaxation rate between
global and slice-selective inversion pulses, as follows:
P~l|
1
T1Slice{Selective

{
1
T1Global
 
Equation 1 - Where P is Neuroperfusion (ml blood/(100 g
tissue*min) and lambda is the blood-brain partition coefficient
for water (90 ml/100 g) as previously described [65,66,67].
Each T1 measurement (selective and global) was quantified
from MR signals at 18 inversion recovery times ranging from
25 ms to 6825 ms, in 400 ms increments. Each image was
acquired with a single-shot echo-planar imaging readout (14.5 ms
echo time, 221 kHz readout bandwidth) with a slice thickness of
1 mm. 5 Mice were dosed with 6Gy radiation and 5 mice with
15Gy.
Perfusion was quantified according to Equation 1 using mean
signals from manually contoured regions-of-interest, highlighting
the hippocampus, on each of the individual FAIR images for each
animal with MIPAV software (National Institutes of Health,
Bethesda, MD).
Histological Analysis: Immunohistochemistry and
Immunofluorescence
Mice were sacrificed according to instituitional guidelines and as
previously described, using PFA perfusion fixation. Two hours
prior to sacrificing mice Bromodeoxyuridine (BrDU) 50 mg/kg
(Sigma) was injected intraperitoneally to highlight proliferation
and 30 min prior to sacrifice Evans blue was injected 1 ml/kg of a
2% solution intravenously to highlight increasing permeability.
Brains were removed and stored in 4% PFA for 24 hours. Brains
were dehydrated in 30% sucrose before being cross-sectioned
coronally at the site of the ICW and embedded in OCT freezing
compound (Tissue-Tek) in a 1 cm
2 mould, snap frozen in liquid
nitrogen and store at 280uC. Frozen 5 mm sections were air dried
at room temperature for 20 min. For immunohistochemical
staining, endogenous peroxidase and biotin activities were blocked
respectively using glucose oxidase and avidin/biotin blocking kits
(Lab Vision). Serum blocking was carried out for 10 min using 5%
serum derived from the secondary antibody source. Sections were
incubated for one hour at room temperature with the primary
antibodies B220 (Ebiosciences 1:100), BrDU (Chemicon, 1:200),
CD11b (BD Pharmingen, 1:50), CD11c (BD Pharmingen, 1:50),
CD3 (Abcam 1:100), CD31 (BD Pharmingen, 1:500), GFAP
(Dako, 1:4000), IBA1 (Wako, 1:200), Ki67 (Dako 1:50), MAC3
(BD Pharmingen, 1:100), SMA (Abcam, 1:1000). Biotinylated
secondary (Vector labs) or fluorescent secondary (Invitrogen) to
the primary antibodies were applied for one hour. Immunohisto-
chemical stains underwent a 30 min horseradish peroxidase-
conjugated ultrastreptavidin labeling (ID labs) treatment and color
was developed using freshly prepared NovaRed solution (Vector
labs), slides were lightly counterstained with hematoxylin, dehy-
drated in alcohols, cleared in xylene and mounted in Permount
(Fisher). Immunofluorescent stained slides were mounted using a
DAPI aqueous mount (Vector Labs) and were stored below 0uC.
For the dual CD31:TUNEL immunohistochemical staining the
primary antibody CD31 was followed with a biotinylated
secondary for 30 min and horseradish peroxidase-conjugated
ultrastreptavidin labeling reagent for 30 min. After washing well
in TBS, color development was done with freshly prepared DAB
solution. Sections were washed well in 3 changes of distilled water.
For the second marker, TUNEL, slides were placed in cold
Alcohol/Acetic acid mixture (2:1) for 5 minutes and rinsed with
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incubated in Biotin-nucleotide cocktail in a water bath at 37uC for
1 to 1.5 hr. After washing well in PBS Alkaline Phosphatase
Strepavidin Reagent was applied for 30 minutes (Vector labs SA-
5100). Further washes in PBS were carried out before color was
developed with freshly prepared Vector Red solution (Vector Labs
SK-5100).
Semi-Quantification Analysis
Ten fields of view at 206were blindly analyzed using Image J
software. First RGB channels were split and converted to 8bit gray
scale images. Background subtraction of 50 pixels equalized all
channels. Threshold levels were adjusted to 45 pixels (min) to
225 pixels (max) in all images to mask the ‘particles’, upon
applying the mask the images were converted to binary images for
analysis. Particle analysis was completed based upon size
restrictions of 8 pixel
2–infinity leaving morphology unspecified
due to the heterogeneous differentiation of the BMDCs, Z-stack
images were analyzed as a block image to allow a semi-
quantification of BMDCs/volume of tissue.
Statistical Analysis
Experiments were carried out in triplicate. For multi-group
comparison an ANOVA statistical test was performed, whilst for
direct comparisons unpaired two-tailed Student’s t-tests were
carried out. We defined *significance at p,0.05. Data was
analyzed using group mean, (n values appear on graphs) with error
bars reported as standard deviation (s.d.).
All animal procedures were carried out according to animal
user protocols approved ethically by the University Health
Network Animal Care Committee under the guidelines of the
Canadian Council on Animal Care..
Supporting Information
Figure S1 Further Characterization of Radiation Effect.
(A) Evans blue perfusion highlights area of increased leakiness in
the right irradiated side of the brain, circled, when compared to
the left non-irradiated side, Macroimaged. (B) Enlarged IBA1
immunofluorescence to further highlight the overlay with BMDCs
in 50% of cases (Green: IBA1, Red: BMDC, Blue: nuclei),4 0 6
magnification.
(TIF)
Figure S2 MRI analysis or Cerebral Blood Flow. (A)
Using FAIR MRI parameters images were uploaded into MiPav
software and cerebral blood flow maps were generated. (B) Graphs
demonstrating the CBF in both the sub-cortical and hippocampal
regions of both the non-irradiated (L) hemisphere and irradiated
(R) hemisphere, demonstrating there is no significant difference in
flow either short term, day 1,3 post RT or long term, day 21 post
RT.
(TIF)
Figure S3 Imaging capabilities. (A) Flattened out Z-stack
image, showing the depth of resolution (Green: BMDC, Blue: CD31),
106magnification. White dashed box demonstrates the position of
zoomed in images in (B). (B) Progressive photos through Z-stack to
demonstrate the definition of cellular morphology available
through the use of Z-stack imaging. It also demonstrates the
closeness of the BMDCs to the vessel walls (Green: BMDC, Blue:
CD31),1 0 6magnification.
(TIF)
Figure S4 Experimental Design and Layout. Schemata
identifying the use of mice along the experimental timeline
highlighting the ability to re image and sac mice at each time point
to corroborate imaging with histology.
(TIF)
Figure S5 Bone Marrow Chimeric Engraftment. (A)U p
to 6 weeks post reconstitution extracted bone marrow can be
examined and analyzed for both +ve (blue circles) and 2ve (Green
circles) fluorescence, to calculate +ve BM uptake as a % of total
cell number. A high magnification image shows more clearly the
cells defined as +ve and 2ve, note that BM in this specimen was
reconstituted with red fluorescent BM. (B) % BM uptake remains
high at 72% even 6 weeks after the BM reconstitution with very
little variation.
(TIF)
Figure S6 Stereotactic Image Guided Radiation. The in-
house designed micro-irradiator allows for pinpoint accuracy of
radiation delivery to the mice. (A) 360u Computer Tomography
imaging is used to position the mouse, ensuring the iso-centre of
radiation, red target, is in the centre of the right hemisphere where
the ICW was generated. (B) An 8*11 mm collimator is used to
ensure there is no leakage of radiation to further areas of the brain
and further CT imaging can be used to position more accurately.
(C) The radiation beam is administered from a gantry, black
arrowhead, which rotates 360u allowing the radiation to be
administered from any position. The mouse platform remains
static in the centre of the radiator, white arrowhead, whilst
radiation is administered A-P, from the top and P-A, from the
bottom. This prevents a gradient of radiation through the tissue as
it travels further from the source.
(TIF)
Video S1 Time Lapse Imaging of BMDCs. Time Lapse
images capturing a 150 msec time window demonstrates the
ability of the imaging to track dynamically the movement of
BMDCs and reconstituted blood through the vessels, (Green:
BMDCs, Blue: CD31)1 0 6magnification.
(MOV)
Video S2 Z-stack imaging of BMDCs. Z-Stack images
capturing a 150 mm depth section of the window every 10 mm
demonstrates the ability of the imaging to enhance the three
dimensional morphology of BMDCs and their relationship to the
vessels, (Green: BMDCs, Blue: CD31)1 0 6magnification.
(MOV)
Acknowledgments
We would like to thank Ab Guha for continued research and intellectual
support to complete this project. Regretably he is recently deceased. We
would like to thank Dr. Warren Foltz for his MRI expertise with both the
acquisition and analysis of the MRI data presented. We thank Brian
Wilson’s and Ralph DaCosta’s group for their help with optical imaging
and James Jonkman for providing expertise in optical imaging. For
assistance with Radiation setup we thank Salomeh Jelveh and Patricia
Lindsay and pathology assistance we thank Melanie Macasaet.
Author Contributions
Conceived and designed the experiments: KB RH GZ. Performed the
experiments: KB GZ. Analyzed the data: KB GZ. Contributed reagents/
materials/analysis tools: KB GZ. Wrote the paper: KB RH GZ.
BMDC Recruitment following Cranial Irradiation
PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e38366References
1. Gaspar LE, Mehta MP, Patchell RA, Burri SH, Robinson PD, et al. (2010) The
role of whole brain radiation therapy in the management of newly diagnosed
brain metastases: a systematic review and evidence-based clinical practice
guideline. Journal of neuro-oncology 96: 17–32.
2. Gondi V, Mehta M (2010) Novel insights into the management of brain
metastases. Current Opinion in Neurology 23: 556–562.
3. Monje ML, Mizumatsu S, Fike JR, Palmer TD (2002) Irradiation induces neural
precursor-cell dysfunction. Nat Med 8: 955–962.
4. Brush J, Lipnick SL, Phillips T, Sitko J, McDonald JT, et al. (2007) Molecular
mechanisms of late normal tissue injury. Semin Radiat Oncol 17: 121–130.
5. Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, et al. (2002) Human
bone marrow stem cells exhibit neural phenotypes and ameliorate neurological
deficits after grafting into the ischemic brain of rats. Exp Neurol 174: 11–20.
6. Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon IM, et al. (2010) Mouse
bone marrow-derived mesenchymal stromal cells turn activated macrophages
into a regulatory-like profile. PLoS One 5: e9252.
7. Jackson KA, Majka SM, Wang H, Pocius J, Hartley CJ, et al. (2001)
Regeneration of ischemic cardiac muscle and vascular endothelium by adult
stem cells. J Clin Invest 107: 1395–1402.
8. Jackson JS, Golding JP, Chapon C, Jones WA, Bhakoo KK (2010) Homing of
stem cells to sites of inflammatory brain injury after intracerebral and
intravenous administration: a longitudinal imaging study. Stem Cell Res Ther
1: 17.
9. Herzog EL, Chai L, Krause DS (2003) Plasticity of marrow-derived stem cells.
Blood 102: 3483–3493.
10. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, et al. (2002) Recruitment of
stem and progenitor cells from the bone marrow niche requires MMP-9
mediated release of kit-ligand. Cell 109: 625–637.
11. Sanchez-Ramos JR (2002) Neural cells derived from adult bone marrow and
umbilical cord blood. J Neurosci Res 69: 880–893.
12. Chen J, Li Y, Chopp M (2000) Intracerebral transplantation of bone marrow
with BDNF after MCAo in rat. Neuropharmacology 39: 711–716.
13. Chen J, Li Y, Wang L, Lu M, Zhang X, et al. (2001) Therapeutic benefit of
intracerebral transplantation of bone marrow stromal cells after cerebral
ischemia in rats. J Neurol Sci 189: 49–57.
14. Chen J, Sanberg PR, Li Y, Wang L, Lu M, et al. (2001) Intravenous
administration of human umbilical cord blood reduces behavioral deficits after
stroke in rats. Stroke 32: 2682–2688.
15. Chen J, Zhang ZG, Li Y, Wang L, Xu YX, et al. (2003) Intravenous
administration of human bone marrow stromal cells induces angiogenesis in the
ischemic boundary zone after stroke in rats. Circ Res 92: 692–699.
16. Chen X, Katakowski M, Li Y, Lu D, Wang L, et al. (2002) Human bone
marrow stromal cell cultures conditioned by traumatic brain tissue extracts:
growth factor production. J Neurosci Res 69: 687–691.
17. Chopp M, Zhang XH, Li Y, Wang L, Chen J, et al. (2000) Spinal cord injury in
rat: treatment with bone marrow stromal cell transplantation. Neuroreport 11:
3001–3005.
18. Kioi M, Vogel H, Schultz G, Hoffman RM, Harsh GR, et al. (2010) Inhibition
of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma
after irradiation in mice. J Clin Invest 120: 694–705.
19. Aghi M, Chiocca EA (2005) Contribution of bone marrow-derived cells to blood
vessels in ischemic tissues and tumors. Molecular therapy : the journal of the
American Society of Gene Therapy 12: 994–1005.
20. Aghi M, Cohen KS, Klein RJ, Scadden DT, Chiocca EA (2006) Tumor stromal-
derived factor-1 recruits vascular progenitors to mitotic neovasculature, where
microenvironment influences their differentiated phenotypes. Cancer Res 66:
9054–9064.
21. Pena LA, Fuks Z, Kolesnick RN (2000) Radiation-induced apoptosis of
endothelial cells in the murine central nervous system: protection by fibroblast
growth factor and sphingomyelinase deficiency. Cancer Res 60: 321–327.
22. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, et al. (2003)
Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science
300: 1155–1159.
23. Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WEF, Goldbrunner R, et
al. (2010) Real-time imaging reveals the single steps of brain metastasis
formation. Nature Medicine 16: 116–122.
24. Li YQ, Jay V, Wong CS (1996) Oligodendrocytes in the adult rat spinal cord
undergo radiation-induced apoptosis. Cancer Res 56: 5417–5422.
25. Li YQ, Chen P, Haimovitz-Friedman A, Reilly RM, Wong CS (2003)
Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing
radiation. Cancer Res 63: 5950–5956.
26. Siegal T, Pfeffer MR, Meltzer A, Shezen E, Nimrod A, et al. (1996) Cellular and
secretory mechanisms related to delayed radiation-induced microvessel
dysfunction in the spinal cord of rats. Int J Radiat Oncol Biol Phys 36: 649–659.
27. Ahn GO, Brown JM (2009) Role of endothelial progenitors and other bone
marrow-derived cells in the development of the tumor vasculature. Angiogenesis
12: 159–164.
28. Rotolo JA, Stancevic B, Lu SX, Zhang J, Suh D, et al. (2009) Cytolytic T cells
induce ceramide-rich platforms in target cell membranes to initiate graft-versus-
host disease. Blood 114: 3693–3706.
29. Kozin SV, Kamoun WS, Huang Y, Dawson MR, Jain RK, et al. (2010)
Recruitment of myeloid but not endothelial precursor cells facilitates tumor
regrowth after local irradiation. Cancer Res 70: 5679–5685.
30. Andrews EM, Tsai SY, Johnson SC, Farrer JR, Wagner JP, et al. (2008) Human
adult bone marrow-derived somatic cell therapy results in functional recovery
and axonal plasticity following stroke in the rat. Exp Neurol 211: 588–592.
31. De Palma M, Naldini L (2006) Role of haematopoietic cells and endothelial
progenitors in tumour angiogenesis. Biochim Biophys Acta 1766: 159–166.
32. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP (2000) Origins of circulating
endothelial cells and endothelial outgrowth from blood. J Clin Invest 105:
71–77.
33. Duda DG, Cohen KS, Kozin SV, Perentes JY, Fukumura D, et al. (2006)
Evidence for incorporation of bone marrow-derived endothelial cells into
perfused blood vessels in tumors. Blood 107: 2774–2776.
34. Au P, Tam J, Fukumura D, Jain RK (2008) Bone marrow-derived mesenchymal
stem cells facilitate engineering of long-lasting functional vasculature. Blood 111:
4551–4558.
35. Coffelt SB, Tal AO, Scholz A, De Palma M, Patel S, et al. (2010) Angiopoietin-2
regulates gene expression in TIE2-expressing monocytes and augments their
inherent proangiogenic functions. Cancer Res 70: 5270–5280.
36. Haimovitz-Friedman A, Kan CC, Ehleiter D, Persaud RS, McLoughlin M, et al.
(1994) Ionizing radiation acts on cellular membranes to generate ceramide and
initiate apoptosis. J Exp Med 180: 525–535.
37. Myers R, Rogers MA, Hornsey S (1986) A reappraisal of the roles of glial and
vascular elements in the development of white matter necrosis in irradiated rat
spinal cord. Br J Cancer Suppl 7: 221–223.
38. van der Kogel AJ (1986) Radiation-induced damage in the central nervous
system: an interpretation of target cell responses. Br J Cancer Suppl 7: 207–217.
39. Paris F, Fuks Z, Kang A, Capodieci P, Juan G, et al. (2001) Endothelial
apoptosis as the primary lesion initiating intestinal radiation damage in mice.
Science 293: 293–297.
40. Ljubimova NV, Levitman MK, Plotnikova ED, Eidus L (1991) Endothelial cell
population dynamics in rat brain after local irradiation. Br J Radiol 64: 934–940.
41. Truman JP, Garcia-Barros M, Kaag M, Hambardzumyan D, Stancevic B, et al.
(2010) Endothelial membrane remodeling is obligate for anti-angiogenic
radiosensitization during tumor radiosurgery. PLoS One 5: e12310.
42. Fuks Z, Kolesnick R (2005) Engaging the vascular component of the tumor
response. Cancer Cell 8: 89–91.
43. Haimovitz-Friedman A, Kolesnick RN, Fuks Z (1997) Differential inhibition of
radiation-induced apoptosis. Stem Cells 15 Suppl 2: 43–47.
44. Asahara T, Masuda H, Takahashi T, Kalka C (1999) Bone marrow origin of
endothelial progenitor cells responsible for postnatal vasculogenesis in
physiological and pathological neovascularization. Circulation.
45. Le Bourhis X, Romon R, Hondermarck H (2010) Role of endothelial progenitor
cells in breast cancer angiogenesis: from fundamental research to clinical
ramifications. Breast Cancer Research and Treatment 120: 17–24.
46. Nolan DJ, Ciarrocchi A, Mellick AS, Jaggi JS, Bambino K, et al. (2007) Bone
marrow-derived endothelial progenitor cells are a major determinant of nascent
tumor neovascularization. Genes & development 21: 1546–1558.
47. Zhang H-r, Chen F-l, Xu C-p, Ping Y-f, Wang Q-l, et al. (2009) Incorporation of
endothelial progenitor cells into the neovasculature of malignant glioma
xenograft. Journal of neuro-oncology 93: 165–174.
48. Gaber MW, Sabek OM, Fukatsu K, Wilcox HG, Kiani MF, et al. (2003)
Differences in ICAM-1 and TNF-alpha expression between large single fraction
and fractionated irradiation in mouse brain. Int J Radiat Biol 79: 359–366.
49. Hong JH, Chiang CS, Tsao CY, Lin PY, McBride WH, et al. (1999) Rapid
induction of cytokine gene expression in the lung after single and fractionated
doses of radiation. Int J Radiat Biol 75: 1421–1427.
50. Hong JH, Jung SM, Tsao TC, Wu CJ, Lee CY, et al. (2003) Bronchoalveolar
lavage and interstitial cells have different roles in radiation-induced lung injury.
Int J Radiat Biol 79: 159–167.
51. Ransohoff RM, Cardona AE (2010) The myeloid cells of the central nervous
system parenchyma. Nature 468: 253–262.
52. Roumier A, Be ´chade C, Poncer J-C, Smalla K-H, Tomasello E, et al. (2004)
Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse.
The Journal of neuroscience : the official journal of the Society for Neuroscience
24: 11421–11428.
53. Coull JAM, Beggs S, Boudreau D, Boivin D, Tsuda M, et al. (2005) BDNF from
microglia causes the shift in neuronal anion gradient underlying neuropathic
pain. Nature 438: 1017–1021.
54. Elkabes S, DiCicco-Bloom EM, Black IB (1996) Brain microglia/macrophages
express neurotrophins that selectively regulate microglial proliferation and
function. Journal of Neuroscience 16: 2508–2521.
55. Marı ´n-Teva J, Dusart I, Colin C, Gervais A, Rooijen N, et al. (2004) Microglia
Promote the Death of Developing Purkinje Cells. Neuron 41: 535–547.
56. Davoust N, Vuaillat C, Androdias G, Nataf S (2008) From bone marrow to
microglia: barriers and avenues. Trends in immunology 29: 227–234.
57. Rivest S (2011) The promise of anti-inflammatory therapies for CNS injuries
and diseases. Expert review of neurotherapeutics 11: 783–786.
58. (2010) Microglial pilgrimage to the brain. Nat Med 16: 1380–1381.
BMDC Recruitment following Cranial Irradiation
PLoS ONE | www.plosone.org 11 June 2012 | Volume 7 | Issue 6 | e3836659. Priller J, Flugel A, Wehner T, Boentert M, Haas C, et al. (2001) Targeting gene-
modified hematopoietic cells to the central nervous system: use of green
fluorescent protein uncovers microglial engraftment. Nature Medicine 7:
1356–1361.
60. Mildner A, Schmidt H, Nitsche M, Merkler D, Hanisch U-K, et al. (2007)
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under
defined host conditions. Nature Neuroscience 10: 1544–1553.
61. Priller J, Persons D, Klett F (2001) Neogenesis of cerebellar Purkinje neurons
from gene-marked bone marrow cells in vivo. The Journal of cell ….
62. Nern C, Wolff I, Macas J, von Randow J (2009) Fusion of Hematopoietic Cells
with Purkinje Neurons Does Not Lead to Stable Heterokaryon Formation under
Noninvasive Conditions. The Journal of ….
63. Simard AR, Rivest S (2006) Neuroprotective properties of the innate immune
system and bone marrow stem cells in Alzheimer’s disease. Molecular Psychiatry
11: 327–335.
64. Simard AR, Soulet D, Gowing G, Julien J-P, Rivest S (2006) Bone marrow-
derived microglia play a critical role in restricting senile plaque formation in
Alzheimer’s disease. Neuron 49: 489–502.
65. Sun Y, Schmidt NO, Schmidt K, Doshi S, Rubin JB, et al. (2004) Perfusion
MRI of U87 brain tumors in a mouse model. Magnetic resonance in medicine :
official journal of the Society of Magnetic Resonance in Medicine/Society of
Magnetic Resonance in Medicine 51: 893–899.
66. Leithner C, Mu ¨ller S, Fu ¨chtemeier M, Lindauer U, Dirnagl U, et al. (2010)
Determination of the brain-blood partition coefficient for water in mice using
MRI. Journal of cerebral blood flow and metabolism : official journal of the
International Society of Cerebral Blood Flow and Metabolism 30: 1821–1824.
67. Herscovitch P, Raichle ME (1985) What is the correct value for the brain–blood
partition coefficient for water? Journal of cerebral blood flow and metabolism :
official journal of the International Society of Cerebral Blood Flow and
Metabolism 5: 65–69.
BMDC Recruitment following Cranial Irradiation
PLoS ONE | www.plosone.org 12 June 2012 | Volume 7 | Issue 6 | e38366